Boka Sciences, headquartered in Utah, is focused on quickly and accurately diagnosing patients who suffer from xerostomia (dry mouth) and other diseases that affect saliva flow. The company is developing a portfolio of products based on its proprietary Bokaflo system.
Our first product, BokaFlo, allows the clinician to diagnose xerostomia—a condition that affects an estimated 60-70 million Americans.
BokaFlo is quick, inexpensive, easy to use, and accurate.
BokaFlo was FDA registered in September 2018.
BokaFlo is also clinically tested and proven to accurately measure salivary flow rate.